AllAnalyst Report
logoMorningstarSeptember 14, 2020

Dr. Reddy's Laboratories Limited: Dr. Reddy's Low-Cost Operations and Emerging-Market Brand Recognition Should Bolster Performance

Symbols
RDY
Sector(s)
Healthcare
Rating
Premium
Current Price
$65.37
Fair Value
Premium
Economic Moat
Premium
Stewardship
Premium
Summary

With headquarters in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceuticals. The firm operates in three divisions: global generics, pharmaceutical services and active ingredients, and proprietary products and other, which make up most of the company's revenue at about 80%, 15%, and 3%. Most of the company’s sales are based in the United States.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE